We are live on ! Find out more
KA

Kintegral Advisory Portfolio holdings

AUM $1.23B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+27.3%
1 Year Est. Return
+40.07%
3 Year Est. Return
+123.97%
5 Year Est. Return
+164.78%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
+$178M
Cap. Flow
+$213K
Cap. Flow %
0.02%
Top 10 Hldgs %
35.96%
Holding
234
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VGNT
Versigent PLC
VGNT
+$213K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 38.65%
2 Financials 16.97%
3 Healthcare 13.16%
4 Communication Services 10.75%
5 Consumer Discretionary 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEYS icon
26
Keysight
KEYS
$55.7B
$11.8M 0.96%
33,663
– –
TXN icon
27
Texas Instruments
TXN
$236B
$11.8M 0.95%
39,516
– –
MA icon
28
Mastercard
MA
$507B
$11.8M 0.95%
22,882
– –
HD icon
29
Home Depot
HD
$320B
$11.3M 0.92%
32,013
– –
AMGN icon
30
Amgen
AMGN
$236B
$10.7M 0.87%
29,489
– –
C icon
31
Citigroup
C
$231B
$9.48M 0.77%
67,756
– –
META icon
32
Meta Platforms (Facebook)
META
$1.57T
$9.47M 0.77%
16,813
– –
STT icon
33
State Street
STT
$53.4B
$9.26M 0.75%
54,595
– –
PG icon
34
Procter & Gamble
PG
$340B
$8.26M 0.67%
56,302
– –
TT icon
35
Trane Technologies
TT
$98.5B
$8.1M 0.66%
16,496
– –
BAC icon
36
Bank of America
BAC
$438B
$7.67M 0.62%
134,540
– –
SPGI icon
37
S&P Global
SPGI
$131B
$7.09M 0.57%
17,403
– –
CB icon
38
Chubb
CB
$132B
$6.89M 0.56%
20,195
– –
BLK icon
39
Blackrock
BLK
$174B
$6.78M 0.55%
7,053
– –
BMY icon
40
Bristol-Myers Squibb
BMY
$136B
$6.69M 0.54%
116,111
– –
MCO icon
41
Moody's
MCO
$85.5B
$6.62M 0.54%
14,623
– –
PEP icon
42
PepsiCo
PEP
$188B
$6.46M 0.52%
47,728
– –
IBM icon
43
IBM
IBM
$221B
$6.38M 0.52%
22,700
– –
CVS icon
44
CVS Health
CVS
$124B
$6.36M 0.52%
61,479
– –
STX icon
45
Seagate
STX
$192B
$6.36M 0.52%
6,581
– –
ECL icon
46
Ecolab
ECL
$78.3B
$5.85M 0.47%
20,956
– –
CRH icon
47
CRH
CRH
$62.7B
$5.77M 0.47%
53,911
– –
CMI icon
48
Cummins
CMI
$77.2B
$5.76M 0.47%
8,072
– –
EW icon
49
Edwards Lifesciences
EW
$51.8B
$5.74M 0.47%
63,507
– –
NDAQ icon
50
Nasdaq
NDAQ
$54.2B
$5.63M 0.46%
71,384
– –
1
2
3 4 5

Similar funds

SPC
Spirepoint Private Client Vero Beach, Florida $1.23B AUM 30.73% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.24B AUM 28.29% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
RPC
Rossmore Private Capital Glastonbury, Connecticut $1.24B AUM 28.92% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM

Kintegral Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, Kintegral Advisory held 234 positions worth $1.23B, up 17% from $1.06B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0.43%. Kintegral Advisory opened 1 new position and made no exits, leaving the 234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • Kintegral Advisory's largest Q2 2026 buy was Versigent PLC: 5,339 shares worth $224K.
  • Kintegral Advisory's ten largest holdings make up 36% of its $1.23B portfolio in Q2 2026.
  • Kintegral Advisory opened 1 new position and closed 0 in Q2 2026.
  • Kintegral Advisory's portfolio value rose 17% quarter-over-quarter to $1.23B.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.